Medical Condition News

RSS

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

25 Sep 2018

Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility

This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.

25 Sep 2018

Harmful H. pylori may play a role in Parkinson's disease

While human genetic mutations are involved in a small number of Parkinson's disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.

25 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more likely to become chronic opioid users than patients treated with minimally invasive surgery, highlighting the need for additional research into how pain management after surgery might be a contributing factor to the opioid addiction crisis, according to a study published in JAMA Oncology in September.

24 Sep 2018

Study sheds light on how brain protein may be involved neurodevelopmental disorders

A study by researchers at Rockefeller University has shown that defects in a brain protein may underlie a number of neurodevelopmental disorders.

24 Sep 2018

TU Wien develops new remedy for celiac disease

Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.

24 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Kessler Foundation researchers have published their findings linking behavioral symptoms with employment outcomes among adults with moderate to severe traumatic brain injury.

24 Sep 2018

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation.

24 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

New virtual diabetes clinic may help manage condition of people with Type 2 diabetes

Blue Cross and Blue Shield of Georgia is taking an innovative approach to helping its consumers who have been diagnosed with Type 2 diabetes manage their condition to improve their health through a new virtual diabetes clinic with a smartphone app and monitoring tools.

24 Sep 2018

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical trials.

24 Sep 2018

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.

24 Sep 2018

Genes predicting person's height may provide clues about causes of varicose veins

A person's height and certain genes that predict height are associated with varicose veins and may provide clues about what causes this condition and ways to prevent and treat it, according to new research in the American Heart Association's journal Circulation.

24 Sep 2018

‘Physicians of the mouth’? Dentists absorb the medical billing drill

On a recent Friday morning, more than 30 dentists and dental staffers gathered in a conference room to learn an arcane new skill: how to bill medical insurers.

24 Sep 2018

New study finds height as possible risk factor for developing varicose veins

The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues to what causes this common but little understood condition.

24 Sep 2018

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

The link between smoking and multiple sclerosis (MS) is “clearer than ever”, the MS Society has announced. Not only are people who smoke more likely to develop MS, smoking can also speed up how fast people with MS become disabled.

24 Sep 2018

New online, sound matching tool offers tinnitus sufferers potential treatment options

A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.

24 Sep 2018

Medical Condition News

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility

Harmful H. pylori may play a role in Parkinson's disease

Your Vision Matters: How to Protect Your Eyesight

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Study sheds light on how brain protein may be involved neurodevelopmental disorders

TU Wien develops new remedy for celiac disease

Gene therapy approach could help treat mitochondrial diseases

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

New virtual diabetes clinic may help manage condition of people with Type 2 diabetes

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

Genes predicting person's height may provide clues about causes of varicose veins

‘Physicians of the mouth’? Dentists absorb the medical billing drill

New study finds height as possible risk factor for developing varicose veins

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

New online, sound matching tool offers tinnitus sufferers potential treatment options

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News